How do you know

Quality market-ready MVPs drive deal flow. By maintaining a strong pipeline, we give our investors better returns and superior opportunities.

Our MVP Accelerator delivers a disciplined, repeatable process — from rigorous sourcing and vetting through to the development of market-ready MVPs.

We don't get lost in too many spreadsheets, polished decks or on-paper projections. We are customer-obsessed builders focused on one thing — getting quality products to market.

We believe informed investors are better partners. Our MVP Accelerator gives investors full visibility into our end-to-end development process — from concept to market-ready MVPs.

Our investment team goes beyond capital. We work alongside founders to realise their vision, unlock the full potential of their business and achieve meaningful growth targets.

At its core, our MVP Accelerator exists to move the needle on what matters most to investors. By maintaining sharp focus on operational due diligence, disciplined software development, and consistently launching high-quality market-ready MVPs, we create the conditions for stronger deal flow, better portfolio performance and improved IRR.

We are currently raising capital for four opportunities. A curated medical certificates platform that is fraud-proof; under the Skin Health Network Australia, a skin cancer app powered by AI for early detection; online rural classifieds and marketplace; and an AI-powered data ecosystem where users own their data. The Health Impact Fund is structured to direct capital to health innovations.

Our Health Impact Fund invests across two distinct categories — established companies and high-growth startups prior to Series A. Qualifying startup investments carry significant tax advantages, including capital gains tax exemption, tax-free income distributions, and a 10% non-refundable offset on committed capital.